New formulations enable oral delivery of therapeutics traditionally delivered intravenously.

Scientists produce a reference map of human protein interactions, releasing data helpful for understanding diseases including cancer and infectious diseases such as COVID-19.

The newly formed Massachusetts Consortium on Pathogen Readiness aims to address both the immediate and long-term implications of the coronavirus crisis. The effort, led by Harvard Medical School, will work to stem the tide of COVID-19 but, more importantly, to lay the groundwork for dealing with future pandemics.

In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy.

Investigators at Massachusetts General Hospital have modified the gene editing system, making it possible to potentially target any location across the entire human genome.

Harvard’s Global Health Institute puts its research expertise into motion, helping hospitals assess capacity and quality of care so they can prepare for COVID-19 patients appropriately.

In response to this public health crisis, researchers in the Precision Vaccines Program at Boston Children’s Hospital are on the front lines of developing a vaccine specially targeted toward older populations

Researchers use zebrafish to explore the connection between specific genetic mutations and group behavior.

Researchers have designed personalized blood biopsies that offer the potential of an early warning signal of breast cancer recurrence.

Researchers have found that Alcoholics Anonymous and related 12-step treatments lessen addiction severity as effectively as other treatments, while reducing health care costs.